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Edited by Lukas HuberAbstract ES cells can self-renew while preserving pluripotency
and are able to diﬀerentiate into many cell types. In both pro-
cesses, diﬀerent signal transduction pathways are implicated,
including the Wnt/b-catenin pathway, which we here further ana-
lyzed. We found that a loss of b-catenin in ES cells leads to al-
tered expression of stem cell marker genes. TCF/b-catenin
reporter gene assays indicate that undiﬀerentiated murine ES
cells are capable of reacting to LiCl and Wnt3a but not Wnt5a
stimulation, but have low endogenous TCF/b-catenin activity.
Oct-3/4, nanog and Wnt11 were able to repress TCF/b-catenin
transcriptional activity. During diﬀerentiation, activation of the
Wnt/b-catenin pathway inﬂuences formation of mesoderm and
cardiomyocytes in a time and dose dependent manner.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Stemness is a unique feature of stem cells deﬁning their prop-
erty to be developmentally paused, while retaining an uncon-
ﬁned ability to diﬀerentiate and self-renew. Initial clariﬁcation
of the transcriptional network underlying stemness in murine
ES cells identiﬁed key transcription factors like Oct3/4, Nanog
and Sox2 as well as extrinsic stimuli for stem cell maintenance
[1]. The Wnt-pathway consists of a well-studied ‘‘canonical’’
part, deﬁning a signaling cascade responsible for the accumula-
tion and nuclear translocation of b-catenin, and ‘‘non-canoni-
cal’’, b-catenin independent branches [2]. Several publications
support a role of Wnt/b-catenin signaling during stem cell
maintenance although the precise mode of action is not yet
clear. Wnt3a conditioned media or BIO, an inhibitor of the
Wnt signaling mediator GSK3, maintained mouse and human
stem cell identity [3]. Hao et al. [4] suggested that Wnts inhibit
diﬀerentiation via upregulation of Stat3, while Ogawa et al. [5]
indicate that Wnt3a conditioned medium had no eﬀect on Stat3
phosphorylation and it was suggested that there is no direct
cross-reactivity between the Wnt and the Lif-pathway but
rather a synergistic eﬀect of both factors. Several Wnts were
implicated to support stem cell propagation [4,6] of which*Corresponding author. Fax: +49 731 500 23277.
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cells [7,8]. However, puriﬁed recombinant Wnt3a protein did
not suﬃce to abolish diﬀerentiation of mouse and human ES
cells [5,6,9]. Furthermore, Wnt signaling has been shown to reg-
ulate diﬀerentiation of murine ES cells or during embryonic
development such as cardiogenesis [10]. In this study, we fur-
ther investigated the contribution of b-catenin signaling for
stem cell maintenance and early diﬀerentiation of ES cells.
Our data suggest that the inﬂuence of Wnt signaling on ES cells
depends on the time point of the treatment and the activating
substances used.2. Materials and methods
Cell culture experiments, reporter gene assays, FACS analysis,
immunﬂuorescence and semi-quantitative RT-PCR experiments were
performed using standard procedures. A detailed description of exper-
iments including a list of used primers is provided within Supplemen-
tary information.3. Results and discussion
3.1. Characterization of b-catenin / ES cells
To further analyse the role of b-catenin in stem cell mainte-
nance we characterized b-catenin deﬁcient murine ES cells gen-
erated in the E14.1 cell line [11]. RT-PCR analysis conﬁrmed
that b-catenin / cells do not express detectable RNA levels
forb-catenin (Fig. 1A). These cells canbe cultured on feeder cells
(Fig. 1B) and on gelatine coated dishes (Fig. 1C) and are positive
for alkaline phosphatase (Fig. 1C). Both, wildtype as well as b-
catenin/ES cells express severalWnt ligands, Frizzled recep-
tors as well as transcription factors of the TCF/LEF family
(Fig. 1D). Immunoﬂuorescence studies (Fig. 1E) indicate that
b-catenin is found predominantly at the membrane of undiﬀer-
entiated wildtype ES cells. Diﬀuse staining of b-catenin, how-
ever, can also be found throughout the cytoplasm and the
nucleus. We conﬁrmed this ﬁnding by making co-culture exper-
iments of wildtype and b-catenin / ES cells showing that the
staining throughout the cytoplasm and the nucleus does not rep-
resent background staining (Fig. 1F). In contrast, the stem cell
marker Oct-3/4 is found exclusively in the nucleus (Fig. 1E).
3.2. b-Catenin contributes to regulation of stemness marker
genes in murine ES cells
If Wnt/b-catenin signaling contributes to stemness, ES cells
should be able to react with b-catenin – TCF/LEF – mediatedblished by Elsevier B.V. All rights reserved.
Fig. 1. Characterization of b-catenin deﬁcient murine embryonic stem cells. (A) RT-PCR analysis indicates that b-catenin / cells do not express
b-catenin. (B) Wildtype E14.1 and b-catenin / ES cells grow on feeder layer cells (FL). (C) Wildtype ES cells as well as b-catenin / cells show
alkaline phosphatase staining. (D) RT-PCR analysis to monitor components of the canonical Wnt-pathway as well as expression of stemness marker
genes in wildtype and b-catenin knock-out ES cells. HPRT was used as loading control for RT-PCR analyses. RT-PCR panels were assembled from
diﬀerent experiments but from identical experiments for individual genes. (E) Intracellular localization of Oct-3/4 and b-catenin in wildtype E14.1 ES
cells as visualized through immunﬂuorescence (IF). DAPI counterstaining (DAPI) and an overlay are shown as well. (F) Immunﬂuorescence of Oct-
3/4 and b-catenin in co-cultures of wildtype E14.1 and b-catenin / ES cells.
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Wnt3a and Wnt5a have been implicated in supporting stem-
ness [3,4,6]. We therefore treated ES cells with diﬀerent doses
of puriﬁed, recombinant Wnt3a, Wnt5a or LiCl. LiCl is an
inhibitor of GSK-3 and is widely used to activate the Wnt/b-
catenin pathway in cell culture and embryogenesis [12]. Both
Wnt3a as well as LiCl (Fig. 2A) resulted in a dose dependent
activation of the pathway using TOPFlash reporter gene as-
says as a read out. In contrast, Wnt5a treatment of ES cells
did not result in an activation of the pathway. Thus, two dif-
ferent Wnt ligands, both previously reported to support stem-
ness of ES cells, clearly have diﬀerent eﬀects on activation of
the Wnt/b-catenin pathway.
Next we compared the expression of genes previously linked
to pluripotency, self-renewal and stemness of ES cells in wild-
type and b-catenin / ES cells. The loss of b-catenin results
in a strong downregulation of Rex-1, dppa-4 and dppa-5,whereas Oct-6 was upregulated (Fig. 1D). Other marker genes
for stemness were slightly but reproducible downregulated
such as nanog, lefty-1, lefty-2, Klf-2 or Sal1 whereas we could
not detect any eﬀect on the expression levels of Id1, Id2, Id3,
STAT-3, Sox2 or Oct-3/4. These data further support the idea
that b-catenin is involved in regulating the expression of stem-
ness marker genes but likely is not required for stem cell main-
tenance since Oct-3/4, nanog, Sox2 or Id1-3 were still
expressed. It needs to be mentioned though that these results
are only based on a single cell line and ideally these results
should be conﬁrmed by use of other, independently generated
b-catenin deﬁcient ES cell lines. These experiments could also
exclude the possibility that the expression of individual genes is
altered during longer culture conditions in a particular cell
line. Interestingly, b-catenin knock-out ES cells show an in-
crease in Oct6 expression which might also contribute for the
strong reduction in Rex-1 mRNA [13]. Mentionable is also
Fig. 2. Activation of the Wnt/b-catenin pathway in murine ES cell. (A) Murine ES cells were transfected with TOPFlash reporter gene and treated
with Wnt3a, Wnt5a or LiCl at indicated concentrations for 24 h. At least three independent measurements per time point were performed. (B)
Untreated E14.1 ES cells show only low TOPFlash activity if at all. n = 18. Data were normalized to FOPFlash reporter. Oct-3/4, nanog and Wnt11
can reduce LiCl induces TOPFlash activity in ES cells (n = 13) or stabilized b-catenin induced TOPFlash activity in HEK293 cells (n = 6–9). Data
were normalized to TOPFlash values in untreated cells. (C) siRNA against Wnt11 reduces endogenous Wnt11 RNA levels. RT-PCR panel was
assembled from the same experiment. In transfection experiments Wnt11 siRNA increases TCF/b-catenin mediated TOPFlash activity (n = 8).
siRNA against Wnt5a was not eﬀective. HPRT was used as internal control for RT-PCR experiments. siRNA against Wnt11 did not change
FOPFlash activity as control (n = 5). Data were normalized to TOPFlash or FOPFlash values, respectively, in control siRNA cells. Error bars
indicate S.E. of the mean.
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together with the loss of Rex-1 and the reduction of Gbx2,
that b-catenin / ES cells exhibit a primitive ectoderm like
or epiblast like [14] gene expression pattern.
To investigate whether this eﬀect of b-catenin might be med-
iated through transcription factors of the TCF/LEF family [2],
the endogenous TCF-mediated gene expression in ES cells was
measured by comparing endogenous TOPFlash activity with a
FOPFlash reporter, which contains no functional TCF/LEF
binding sites [15]. In several experiments, we could detect only
a minimal TCF/b-catenin mediated reporter activity if at all
(Fig. 2B). This observation is in agreement with published data
by others [5,16–19] that could not demonstrate any or only low
TOPﬂash activity in ES cells. We therefore hypothesize that
the eﬀect of b-catenin on stemness marker gene expression
might be mediated at least in part by other factors than
TCF/LEF. One might argue that a loss of b-catenin results
in defects in cadherin mediated cell–cell adhesion. However,
it has been shown that plakoglobin can compensate the loss
of b-catenin in cell adhesion in F9 teratocarcinoma stem cells
[20]. b-Catenin has been shown to be localized in the nucleusof undiﬀerentiated ES cells [21,22] and our ﬁnding of a diﬀuse
staining of b-catenin throughout the cytoplasm and the nu-
cleus of stem cells is in agreement with these reports. b-Catenin
has recently been shown to interact with transcription factors
other than TCF/LEF, i.e, KLF-4 [23], Sox-2 [24] and just
recently, Oct-3/4 [21], none of which can be monitored through
the TOPﬂash reporter. In particular, Takao et al. just recently
demonstrated that b-catenin can interact with Oct-3/4 and that
this interaction is likely involved in regulating the nanog gene
[21]. Consistently, Cao et al. demonstrated that the corre-
sponding Xenopus Oct homologs Oct-25 and Oct-60 repress
TCF/b-catenin signaling in early Xenopus embryos [25].
3.3. Oct-3/4, nanog and Wnt11 act as negative regulators of Wnt
signaling
We therefore analyzed whether well-known regulators of
stemness in murine ES cells, Oct-3/4 and nanog, or a known
antagonist of Wnt/b-catenin signaling, Wnt-11 [26], might act
as negative regulators of the Wnt/b-catenin pathway. Oct-3/4,
nanog and Wnt11 were able to inhibit LiCl or b-catenin med-
iated activation of the Wnt-pathway in E14.1 cells or in human
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As Wnt11 is able to repress TOPFlash activity in both cell
types and as Wnt11 has been shown to be a repressor of b-cate-
nin signaling in P19 cells, we next investigated whether Wnt11
contributes to the low TCF/b-catenin activity in undiﬀerenti-
ated ES cells. To test this hypothesis we transfected undiﬀeren-
tiated ES cells with commercially available siRNA directed
against Wnt11 leading to a downregulation of Wnt11 RNA
(Fig. 2C). Measuring TCF/b-catenin mediated gene activity,
we observed an increase in TOPFlash activity (Fig. 2C) indi-
cating that Wnt11 functions as a repressor of Wnt/b-catenin
signaling in ES cells. siRNA against Wnt-5A however was
not eﬀective.
3.4. Treatment of ES cells with LiCl results in delayed
diﬀerentiation
In a second line of experiments we investigated the inﬂuence
of activating the Wnt/b-catenin pathway on diﬀerentiation of
ES cells. Treatment of embryoid bodies with LiCl from days
0 to 4 of diﬀerentiation resulted in a prolonged expression of
Oct-3/4, nanog, Rex-1, dppa-4, dppa-5 in three out of four
experiments in comparison to untreated controls (Fig. 3). At
the same time, expression of the mesodermal marker gene
Brachyury [27,28] is also extended, suggesting that diﬀerentia-
tion of these embryoid bodies is delayed. We next analysed theFig. 3. Activation of the Wnt/b-catenin pathway by LiCl in diﬀerentiating e
expression of diﬀerentiation marker genes. The expression of marker genes in
6, 8 and 10 of diﬀerentiation and compared between untreated (left) and LiC
diﬀerent experiments but from identical experiments for individual genes.expression of diﬀerentiation marker genes of the cardiac line-
age. Whereas we could not observe a signiﬁcant change in
expression for Nkx2.5, other marker genes showed a delay
or a reduction in expression (Tbx-5, Mef2C, Isl-1, cardiac actin
or a-MHC). In summary, these data indicate, that treatment of
ES cells with LiCl leads to a delay in diﬀerentiation.
3.5. LiCl treatment inﬂuences onset of Brachyury expression in
embryoid bodies
To monitor diﬀerentiation in embryoid bodies on a cellular
level we made use of an ES cell line in which GFP was knocked
into one allele of the Brachyury locus and marks mesodermal
cells [28]. Treatment of embryoid bodies derived from this cell
line with LiCl from days 0 to 4 of diﬀerentiation resulted in a
severe reduction of GFP-positive cells at day 5 (Fig. 4A) which
was quantiﬁed by FACS analyses (Fig. 4B). To monitor
whether activation of the Wnt/b-catenin pathway results in a
delay of diﬀerentiation we performed time course analyses of
GFP-expressing cells. Whereas untreated embryoid bodies of
Bry-GFP cells showed a maximum of GFP expression at day
5, LiCl (days 0–4) treated embryoid bodies reached their max-
imum at day 7 (Fig. 4C). Recent reports suggested that
Brachyury is a positive target gene of the Wnt/b-catenin path-
way [29,30]. In a next step, we therefore analyzed the inﬂuence
of shorter LiCl treatment on GFP expression in Bry-GFP cells.mbryoid bodies prolongs expression of stemness genes and delays the
diﬀerentiating embryoid bodies was analyzed by RT-PCR at days 2, 4,
l treated embryoid bodies (right). RT-PCR panel was assembled from
Fig. 4. Activation of the Wnt/b-catenin pathway delays diﬀerentiation in embryoid bodies. Brachyury-GFP (Bry-GFP) knock-in ES cells were used
to monitor diﬀerentiation. (A) LiCl treatment from days 0 to 4 of diﬀerentiation reduces the expression GFP in day 5 embryoid bodies. (B)
Quantiﬁcation of GFP-expressing Bry-GFP ES cells by FACS at day 2 and 5 of diﬀerentiation in untreated and LiCl treated (days 0–4) ES cells. (C)
Kinetics of GFP expression in Bry-GFP cells is altered by diﬀerent timeframes of LiCl incubation. (D) Quantitative analysis of GFP expression in
Bry-GFP cells using days of maximal GFP expression (upper panel, n = 14) and the location in time of the center of gravity (CoG) of the area under
the curve (lower panel, n = 13). Statistical evaluation was done with a two-sided paired exact Wilcoxon rank sum test. CGR-8-MHC-GFP cells were
used to monitor formation of terminally diﬀerentiated cardiomyocytes as indicated by a contractile phenotype (n = 4) (E) or cardiac MHC driven
GFP expression (F) after treatment with LiCl from days 0 to 4 in comparison to untreated controls. In F a representative view is given. Error bars
indicate S.E. of the mean.
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also leads to a delay in Bry expression, whereas a treatment
from day 2 to 4 results in a slightly earlier expression of
Brachyury (Fig. 4C). These data indicate that the delay in
ES cell diﬀerentiation triggered through LiCl treatment can
only be observed when treatment starts with ES cells that are
still in the undiﬀerentiated state and, vice versa, that treatment
is not eﬀective when diﬀerentiation has already started. During
the time window when the endogenous Brachyury locus is
open starting at day 3, however, LiCl treatment results in an
activation of the gene which is in agreement with the above
mentioned earlier reports. Determining the maximum of
GFP expression or the location in time of the center of gravity
for the area under the curve indicates that treatment of LiCl
signiﬁcantly alters the velocity of diﬀerentiation (Fig. 4D).
To investigate the eﬀect of LiCl on terminal diﬀerentiation
we analysed the formation of a contractile phenotype in diﬀer-
entiating embryoid bodies. For this purpose we used CGR-8
ES cells with a cardiac speciﬁc MHC-GFP reporter, that give
rise to GFP-positive cardiomyocytes [31]. Treatment of embry-
oid bodies with LiCl during days 0–4 leads to a signiﬁcant de-
lay in formation of a contractile phenotype (Fig. 4E) and
reduced number of GFP-positive cells (Fig. 4F). Furthermore,
the potential to diﬀerentiate into cardiomyocytes is reduced as
less embryoid bodies ﬁnally show contractile foci that are in
addition smaller in size.
These b-catenin gain of function data were derived through
treating embryoid bodies with LiCl. Although one can not ex-
clude the possibility that LiCl has additional eﬀects other than
inhibiting GSK3, we would like to conclude that these eﬀects
were due to a stabilization and accumulation of b-catenin forseveral reasons. First, we received complementary results for
the b-catenin loss of function situation and the LiCl treatment.
Second, LiCl treatment of murine ES cells results in an upreg-
ulation of a TCF/LEF driven reporter as does treatment with
Wnt3a. Third, it has been shown recently that stable transfec-
tion of murine ES cells with b-catenin results in a prolonged
expression of stemness marker genes upon LIF withdrawal
[21]. Fourth, treatment of ES cells with Wnt3a conditioned
media maintained expression of Oct-3/4, Sox2 and Rex-1 for
several days [5]. Finally, our new data provided here comple-
ment recent publications suggesting a role for b-catenin signal-
ing in murine ES cells [3–6]. Based on our here provided data
and those of others we conclude that b-catenin signaling sup-
ports stemness.
3.6. Wnt treatment inhibits or activates cardiomyocyte
formation depending on treatment time
We next analyzed whether puriﬁed Wnt3a has the same ef-
fect on cardiomyocyte formation as has LiCl. As in case of
LiCl, Wnt3A treatment (100 ng/ml, days 0–4) resulted in a dra-
matic decrease of contracting embryoid bodies (Fig. 5A).
Again we dissected this four day time window and treated
ES cells from days 0 to 2 and from days 2 to 4. These experi-
ments revealed, that treatment from days 2 to 4 also results in
an inhibition of cardiomyocyte formation whereas treatment
from days 0 to 2 promotes cardiomyocyte formation
(Fig. 5A) indicating a biphasic inﬂuence of Wnt3a. As the sup-
portive role of Wnt3a on cardiogenesis (days 0–2) could not
have been anticipated from the comparable experiments using
LiCl as an activator of b-catenin signaling (see Fig. 4) we also
investigated the inﬂuence of Wnt3a treatment on Brachyury
Fig. 5. (A) Treatment of Bry-GFP knock in ES cells with Wnt3a (100 ng/ml) from days 0 to 4 or days 2 to 4 reduces formation of a contractile
phenotype at day 10, whereas treatment from days 0 to 2 enhanced cardiomyocyte formation. Data of nine representative experiments as well as the
average are shown. (B) Treatment of Bry-GFP knock in murine ES cells with Wnt3a (100 ng/ml) slightly increases number of Bry-positive cells at day
4 (n = 16) at all tested conditions. (C) This eﬀect is more clearly seen when selecting diﬀerentiation experiments in which the number of Bry-positive
cells at day 4 was below 50% (n = 9, low velocity). (D) This eﬀect could not be seen in experiments with a high number of GFP-positive cells at day 4
(n = 7, high velocity). (E) Treatment with a higher concentration of Wnt3a (400 ng/ml) between day 0 and 2 results in a modest decrease of Bry-
positive cells at day 4 (n = 9). Error bars indicate S.E. of the mean.
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diﬀerentiating embryoid bodies with Wnt3a and measured the
number of Bry-positive cells by FACS. Taking all these exper-
iments into account we did not observe a relevant inﬂuence of
Wnt3a on mesoderm induction (Fig. 5B). When separating the
aforementioned set of data into slowly diﬀerentiating cultures
and faster developing cultures (less or more than 50% GFP-po-
sitive cells at day 4), we indeed observed a positive inﬂuence of
Wnt3a on Bry expression in slow cultures for all tested condi-
tions at day 4 of diﬀerentiation (Fig. 5C), while this eﬀect could
not be seen in experiments that already reached high levels of
Bry-positive cells at day 4 (Fig. 5D). Furthermore, using high-
er concentrations of Wnt3a (400 ng/ml) rather led to an inhibi-
tion of Brachyury induction (Fig. 5E), which indicates a dose
dependent eﬀect of Wnt3a.
These data suggest a biphasic function of b-catenin signaling
during cardiomyogenesis as also indicated recently [22,32]. If
time, however, plays an important role in this context, thanthe velocity of diﬀerentiation of ES cells in a particular exper-
iment is a critical aspect. When comparing the maxima of
Brachyury expression in our study and in diﬀerent papers
one can ﬁnd values ranging between day 3 and 8 [22,28,32].
Based on published [22,32,33] and our data, we conclude, that
Wnt3a treatment enhances cardiogenesis before or during the
onset of Brachyury expression but inhibits cardiogenesis once
a signiﬁcant number of Brachyury positive cells have been gen-
erated. Similarly, Ueno et al. [32] suggested that Wnt/b-catenin
signaling supports cardiogenesis before gastrulation but inhib-
its cardiogenesis after onset of gastrulation. If Wnt3a supports
formation of Bry-positive cells in all tested conditions (days 0–
2, 0–4 and 2–4), why does treatment with Wnt3a between day 2
and 4 in our hands inhibit cardiomyocyte formation? An an-
swer might be provided by Kattman et al. [34] who observed
that belated mesodermal cells inherit the cardiovascular poten-
tial, while an earlier population does not. Thus exogenous acti-
vation of the Wnt-pathway from days 2 to 4, which accelerates
R. Anton et al. / FEBS Letters 581 (2007) 5247–5254 5253mesoderm formation could for example promote the genera-
tion of cell identities of the early population with the low car-
diovascular potential.
The diﬀerent eﬀects between initial LiCl and Wnt3a treat-
ment on mesoderm and cardiomyocyte formation could reﬂect
diﬀerent doses of b-catenin signaling triggered by the diﬀerent
stimuli, diﬀerent kinetics with respect to onset of b-catenin sig-
naling upon treatment or even a more complex response of the
Wnt signaling network [2] after Wnt3a stimulation in contrast
to inhibition of GSK-3b upon LiCl treatment. Furthermore it
may be possible that both stimuli diﬀerentially regulate the
assembly of an TCF/b-catenin mediated co-activator/repressor
complex [35]. Also one can not exclude Wnt-pathway indepen-
dent eﬀects of the LiCl treatment as a reason for the diﬀerent
eﬀects. These alternatives need further investigations in the
future.
In summary we have shown in this study that b-catenin con-
tributes to maintenance of the stemness network in murine ES
cells. Our ﬁndings also support the idea that the contribution
of b-catenin to stemness likely is mediated at least in part
through other factors than TCF/LEF like Oct-3/4. During
early diﬀerentiation of murine embryonic stem cells the eﬀect
of Wnt/b-catenin signaling is likely time and dose dependent.
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